0000939798-16-000103.txt : 20160122 0000939798-16-000103.hdr.sgml : 20160122 20160122170442 ACCESSION NUMBER: 0000939798-16-000103 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160119 ITEM INFORMATION: Unregistered Sales of Equity Securities FILED AS OF DATE: 20160122 DATE AS OF CHANGE: 20160122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 161356802 BUSINESS ADDRESS: STREET 1: 4830 W KENNEDY BLVD STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33609 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 4830 W KENNEDY BLVD STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33609 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 8-K 1 oxiseightkthreezerotwo.htm OXIS 8-K SALE OF UNREGISTERED SECURITIES oxiseightkthreezerotwo.htm
 



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 19, 2016

OXIS INTERNATIONAL, INC.
 (Exact name of Registrant as specified in its charter)
____________________

Delaware
(State or other Jurisdiction of Incorporation or organization)
000-08092
(Commission File Number)
94-1620407
(IRS Employer I.D. No.)
___________________________
 
100 South Ashley Drive
Suite 600
Tampa, FL 33602
Phone: (800) 304-9888
(Address, including zip code, and telephone and facsimile numbers, including area code, of
registrant’s executive offices)
___________________________

4830 West Kennedy Blvd
Suite 600
Tampa, FL 33609
 
 (Former name, former address and former fiscal year, if changed since last report)


 
 
 


ITEM 3.02 Unregistered Sales of Equity Securities

OXIS International, Inc. (the “Company”) has issued an aggregate of 12,001,540 shares of common stock to a total of 22 persons or entities in exchange of the cancellation of warrants on a cashless basis.  The shares issued were exempt from the registration requirements of Section 5 of the Securities Act of 1933 (the “Act”) pursuant to Section 4(2) of the Act since the shares were issued to persons or entities closely associated with the Company and there was no public offering of the shares.

The Company also issued an aggregate of 2,133,125 shares of common stock to a total of 13 persons as payment for consulting services provided to the Company.  The average valuation of these shares was $2.50 per share. These shares were also exempt from the registration requirements of Section 5 of the Act pursuant to Section 4(2) of the Act since the shares were also issued to persons closely associated with the Company and there was no public offering of the shares.

The Company also issued an aggregate of 4,612,341 shares of common stock to two executive officers of the Company in fulfilment of contractual rights held by the officers pursuant to their employment agreements.  These shares were also exempt from the registration requirements of Section 5 of the Act pursuant to Section 4(2) of the Act since the shares were also issued to persons closely associated with the Company and there was no public offering of the shares.

Following the issuance of the shares as set forth above, the Company has 21,147,006 common shares issued and outstanding.

 
 
SIGNATURE PAGE

Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
                                                                                                                       Oxis International, Inc.

Dated: January 22, 2016                                                                             By:    /s/ Steven Weldon
Steven Weldon
Chief Financial Officer